Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study

Saved in:
Bibliographic Details
Published inGynecologic oncology Vol. 137; p. 12
Main Authors Sill, M, Monk, B.J, Penson, R.T, Lankes, H, Leitao, M.M, Ramondetta, L.M, Van Le, L, Richardson, D.L, Landrum, L.M, DiSilvestro, P.A, Behbakht, K, Ueland, F.R, Michael, H, Birrer, M.J
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.04.2015
Subjects
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Online AccessGet full text

Cover

More Information
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2015.01.026